Curanex Pharmaceuticals Inc Common Stock is a publicly traded company trading on NASDAQ, led by CEO Jun Liu, with a market cap of $13.3M.
Common questions about Curanex Pharmaceuticals Inc Common Stock
Curanex Pharmaceuticals Inc Common Stock is scheduled to report earnings for Q1 2026 on May 10, 2026.
We use cookies for analytics. See our Privacy and Cookie Policy.